Literature DB >> 25810335

Stroke and anticoagulation in heart failure without atrial fibrillation: from risk to opportunity.

Shunichi Homma1, Siqin Ye2.   

Abstract

Entities:  

Keywords:  Editorials; anticoagulants; heart failure

Mesh：

Substances：

Year:  2015        PMID： 25810335      PMCID： PMC4414909          DOI： 10.1161/CIRCULATIONAHA.115.016329

Source DB:  PubMed          Journal:  Circulation        ISSN： 0009-7322            Impact factor:   29.690


× No keyword cloud information.
  18 in total

1.  Heart disease and stroke statistics--2015 update: a report from the American Heart Association.

Authors:  Dariush Mozaffarian; Emelia J Benjamin; Alan S Go; Donna K Arnett; Michael J Blaha; Mary Cushman; Sarah de Ferranti; Jean-Pierre Després; Heather J Fullerton; Virginia J Howard; Mark D Huffman; Suzanne E Judd; Brett M Kissela; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Simin Liu; Rachel H Mackey; David B Matchar; Darren K McGuire; Emile R Mohler; Claudia S Moy; Paul Muntner; Michael E Mussolino; Khurram Nasir; Robert W Neumar; Graham Nichol; Latha Palaniappan; Dilip K Pandey; Mathew J Reeves; Carlos J Rodriguez; Paul D Sorlie; Joel Stein; Amytis Towfighi; Tanya N Turan; Salim S Virani; Joshua Z Willey; Daniel Woo; Robert W Yeh; Melanie B Turner
Journal:  Circulation       Date:  2014-12-17       Impact factor: 29.690

2.  Efficacy of antithrombotic therapy in chronic heart failure: the HELAS study.

Authors:  Dennis V Cokkinos; George C Haralabopoulos; John B Kostis; Pavlos K Toutouzas
Journal:  Eur J Heart Fail       Date:  2006-06-05       Impact factor: 15.534

Review 3.  Risk-benefit profile of warfarin versus aspirin in patients with heart failure and sinus rhythm: a meta-analysis.

Authors:  Meng Lee; Jeffrey L Saver; Keun-Sik Hong; Hsiu-Chuan Wu; Bruce Ovbiagele
Journal:  Circ Heart Fail       Date:  2012-12-21       Impact factor: 8.790

4.  Quality of anticoagulation control in preventing adverse events in patients with heart failure in sinus rhythm: Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction trial substudy.

Authors:  Shunichi Homma; John L P Thompson; Min Qian; Siqin Ye; Marco R Di Tullio; Gregory Y H Lip; Douglas L Mann; Ralph L Sacco; Bruce Levin; Patrick M Pullicino; Ronald S Freudenberger; John R Teerlink; Susan Graham; J P Mohr; Arthur J Labovitz; Richard Buchsbaum; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker
Journal:  Circ Heart Fail       Date:  2015-04-07       Impact factor: 8.790

5.  ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC.

Authors:  John J V McMurray; Stamatis Adamopoulos; Stefan D Anker; Angelo Auricchio; Michael Böhm; Kenneth Dickstein; Volkmar Falk; Gerasimos Filippatos; Cândida Fonseca; Miguel Angel Gomez-Sanchez; Tiny Jaarsma; Lars Køber; Gregory Y H Lip; Aldo Pietro Maggioni; Alexander Parkhomenko; Burkert M Pieske; Bogdan A Popescu; Per K Rønnevik; Frans H Rutten; Juerg Schwitter; Petar Seferovic; Janina Stepinska; Pedro T Trindade; Adriaan A Voors; Faiez Zannad; Andreas Zeiher; Jeroen J Bax; Helmut Baumgartner; Claudio Ceconi; Veronica Dean; Christi Deaton; Robert Fagard; Christian Funck-Brentano; David Hasdai; Arno Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Theresa McDonagh; Cyril Moulin; Bogdan A Popescu; Zeljko Reiner; Udo Sechtem; Per Anton Sirnes; Michal Tendera; Adam Torbicki; Alec Vahanian; Stephan Windecker; Theresa McDonagh; Udo Sechtem; Luis Almenar Bonet; Panayiotis Avraamides; Hisham A Ben Lamin; Michele Brignole; Antonio Coca; Peter Cowburn; Henry Dargie; Perry Elliott; Frank Arnold Flachskampf; Guido Francesco Guida; Suzanna Hardman; Bernard Iung; Bela Merkely; Christian Mueller; John N Nanas; Olav Wendelboe Nielsen; Stein Orn; John T Parissis; Piotr Ponikowski
Journal:  Eur J Heart Fail       Date:  2012-08       Impact factor: 15.534

Review 6.  Does heart failure confer a hypercoagulable state? Virchow's triad revisited.

Authors:  G Y Lip; C R Gibbs
Journal:  J Am Coll Cardiol       Date:  1999-04       Impact factor: 24.094

7.  Randomized trial of warfarin, aspirin, and clopidogrel in patients with chronic heart failure: the Warfarin and Antiplatelet Therapy in Chronic Heart Failure (WATCH) trial.

Authors:  Barry M Massie; Joseph F Collins; Susan E Ammon; Paul W Armstrong; John G F Cleland; Michael Ezekowitz; Syed M Jafri; William F Krol; Christopher M O'Connor; Kevin A Schulman; Koon Teo; Stuart R Warren
Journal:  Circulation       Date:  2009-03-16       Impact factor: 29.690

8.  Manifestations of coronary disease predisposing to stroke. The Framingham study.

Authors:  W B Kannel; P A Wolf; J Verter
Journal:  JAMA       Date:  1983-12-02       Impact factor: 56.272

9.  Rethinking composite end points in clinical trials: insights from patients and trialists.

Authors:  Joshua M Stolker; John A Spertus; David J Cohen; Philip G Jones; Kaushik K Jain; Emily Bamberger; Brady B Lonergan; Paul S Chan
Journal:  Circulation       Date:  2014-09-08       Impact factor: 29.690

10.  The Warfarin/Aspirin Study in Heart failure (WASH): a randomized trial comparing antithrombotic strategies for patients with heart failure.

Authors:  J G F Cleland; I Findlay; S Jafri; G Sutton; R Falk; C Bulpitt; C Prentice; I Ford; Adele Trainer; P A Poole-Wilson
Journal:  Am Heart J       Date:  2004-07       Impact factor: 4.749
View more
  2 in total

1.  CHA2 DS2 -VASc score and adverse outcomes in patients with heart failure with reduced ejection fraction and sinus rhythm.

Authors:  Siqin Ye; Min Qian; Bo Zhao; Richard Buchsbaum; Ralph L Sacco; Bruce Levin; Marco R Di Tullio; Douglas L Mann; Patrick M Pullicino; Ronald S Freudenberger; John R Teerlink; J P Mohr; Susan Graham; Arthur J Labovitz; Conrado J Estol; Dirk J Lok; Piotr Ponikowski; Stefan D Anker; Gregory Y H Lip; John L P Thompson; Shunichi Homma
Journal:  Eur J Heart Fail       Date:  2016-07-21       Impact factor: 15.534

2.  Ejection fraction, B-type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure.

Authors:  Barry Greenberg; Eric D Peterson; Jeffrey S Berger; François Laliberté; Qi Zhao; Guillaume Germain; Dominique Lejeune; Jennifer W Wu; Patrick Lefebvre; Gregg C Fonarow
Journal:  Clin Cardiol       Date:  2019-01-07       Impact factor: 2.882
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.